Home Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly
 

Keywords :   


Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly

2015-02-11 03:12:04| Biotech - Topix.net

Bothell-based biotech Seattle Genetics , which develops cancer treatments, posted a $27 million loss on revenue of $74 million in its fourth quarter earnings today. While the company's overall sales of $74 million in the fourth quarter increased from $67 million in fourth quarter 2013, its losses also increased to $27 million from $15.7 million during the same quarter a year ago.

Tags: up stock lead loss

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
More »